Overview

Efficacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.

Status:
Unknown status
Trial end date:
2018-07-15
Target enrollment:
Participant gender:
Summary
a prospective, randomized, placebo-controlled study will be conducted to investigate whether hyoscine-n-butylbromide has preventive effects on early postoperative CRBD in patients with urinary catheters who will undergo elective cesarean sections.
Phase:
N/A
Details
Lead Sponsor:
Cairo University
Treatments:
Butylscopolammonium Bromide
Scopolamine
Scopolamine Hydrobromide